Angiotensin receptor blockers (ARBs) vs another ARB
Doubling of SCr4 · people with diabetes and kidney disease
Angiotensin receptor blocker (ARB) showed no clear difference in doubling of SCr4 compared with another ARB (low certainty).
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes onlyRR 1 [0.2, 4.94]1 study · 857 participantsLow